Literature DB >> 21840745

[Anti-Mullerian hormone and polycystic ovary syndrome].

S Catteau-Jonard1, D Dewailly.   

Abstract

Anti-Müllerian hormone (AMH) is known to be secreted in women by granulosa cells of growing follicles from the primary to the large antral follicle stage. Serum and intrafollicular AMH levels are elevated in patients with polycystic ovary syndrome (PCOS) due to increased number of small follicles and an increased secretion within each of these small follicles. This excess of AMH is strongly suspected to play a role in the follicular arrest of PCOS by a negative action on aromatase expression and on action of FSH. The interest of serum AMH assay is also clinically important because AMH level is more sensitive, more specific and reproducible from one center to another as the follicle count. Rates above 5ng/ml or 35pmol/l may be considered as a diagnostic criterion for PCOS.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840745     DOI: 10.1016/j.gyobfe.2011.07.004

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  4 in total

Review 1.  Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function.

Authors:  Anne-Laure Barbotin; Maëliss Peigné; Samuel Andrew Malone; Paolo Giacobini
Journal:  Neuroendocrinology       Date:  2019-07-05       Impact factor: 4.914

2.  Anti-Müllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF.

Authors:  Pierre Lehmann; Maria P Vélez; Julio Saumet; Louise Lapensée; Wael Jamal; François Bissonnette; Simon Phillips; Isaac-Jacques Kadoch
Journal:  J Assist Reprod Genet       Date:  2014-02-27       Impact factor: 3.412

3.  Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study).

Authors:  Eser Sefik Ozyurek; Tevfik Yoldemir; Gokhan Artar
Journal:  J Ovarian Res       Date:  2017-05-12       Impact factor: 4.234

4.  Brown Adipose Transplantation Improves Polycystic Ovary Syndrome-Involved Metabolome Remodeling.

Authors:  Lihua Yao; Qin Wang; Runjie Zhang; Xingyun Wang; Yiwen Liu; Fangfang Di; Liwen Song; Siliang Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-29       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.